Filed Under:

New Drug Focuses Attention On HIV Prevention

Play associated audio
Following the FDA approval of Truvada — the once-a-day pill that can drastically lower a person's risk of contracting HIV — Audie Cornish talks with Dr. Wafaa El-Sadr of Columbia University's Mailman School of Public Health. They examine the status of HIV prevention efforts in the U.S. today — what progress has been made and the challenges that still ahead. El-Sadr has worked on HIV/AIDS prevention and treatment since 1981.
NPR

A Compelling Plot Gives Way To Farce In Franzen's Purity

The new novel reveals sharp observations and a great, sprawling story. But critic Roxane Gay says the book gets bogged down with absurdly-drawn characters and misfired critiques of modern life.
NPR

Huge Fish Farm Planned Near San Diego Aims To Fix Seafood Imbalance

The aquaculture project would be the same size as New York's Central Park and produce 11 million pounds of yellowtail and sea bass each year. But some people see it as an aquatic "factory farm."
WAMU 88.5

Europe's Ongoing Migrant And Refugee Crisis And The Future Of Open Borders

The Austria-Hungary border has become the latest pressure point in Europe's ongoing migrant crisis. An update on the huge influx of migrants and refugees from the Middle East and Africa and the future of open borders within the E.U.

WAMU 88.5

Environmental Outlook: How to Build Smarter Transportation And More Livable Cities

A new report says the traffic in the U.S. is the worst it has been in years. Yet, some urban transportation experts say there's reason to be optimistic. They point to revitalized city centers, emerging technology and the investment in alternative methods of transportation. A conversation about how we get around today, and might get around tomorrow.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.